Skip to content
thispeptide

Big Easy Weight Loss

Big Easy connects patients with named clinical and pharmacy partners. Its longer payment plans, fulfillment terms and pharmacy inspection records need careful comparison before enrollment.

Review by Leah Garner, clinical-evidence editor · Updated October 2026

The short version

The live physician relationship and continuing access are meaningful strengths. Confirm the actual pharmacy, preparation and package terms, and discuss relevant regulatory history rather than relying on broad claims about compounding standards.

Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Big Easy Weight Loss describes its role as a technology platform connecting patients with independent physicians. Its current treatment pages cover compounded semaglutide, tirzepatide, NAD+ and sermorelin. The platform says it does not share ownership with a pharmacy, while its partner list includes several dispensing and production arrangements. That offers potential choice, but the exact pharmacy can affect price, state availability and turnaround. Patients should distinguish the platform, treating physician, producing facility and dispensing pharmacy. A familiar name on a partner list does not establish which organization is handling an individual prescription.

What Big Easy Weight Loss prescribes, by goal

Weight

  • TirzepatideFDA-approved
    • Injection (compounded)Price not published
  • SemaglutideFDA-approved

    Listed by the seller; no price we hold.

    Semaglutide and tirzepatide are sold through compounded treatment packages, with a choice of pharmacy and formulation considered by the physician. The site says treatment pricing does not change with the current dose, while pharmacy selection can change the package quote. That is different from every pharmacy and preparation having one universal price. Ask which exact product, dose schedule and source appear on the prescription.

    Longevity

    • NAD+Compounding conditions apply
      • Injection (compounded)Price not published

    The NAD+ page describes home subcutaneous administration, and the sermorelin page describes a subcutaneous nighttime preparation. Both use an eight-week package description. Their energy, recovery, sleep and body-composition benefits are presented as possible or reported experiences, not guaranteed clinical outcomes. A clinician should explain why either preparation is appropriate and what monitoring is needed. The mechanism of a molecule alone cannot establish that a patient will experience every advertised benefit.

    Recovery

    • SermorelinCompounding conditions apply
      • Injection (compounded)Price not published

    Sleep

    • SermorelinCompounding conditions apply
      • Injection (compounded)Price not published

    Who prescribes

    A licensed clinician

    The public roster names individual clinicians and identifies Gabriel Lasala as chief medical officer. The FAQ says physicians contract independently with the platform rather than through a larger prescribing network. The pricing page also promises that the appointment is with a physician. Those are specific care-model disclosures, though the assigned professional and state license still need confirmation. The practice describes compensation for physician time rather than commissions for prescribing. That is a company statement about its arrangement, not an independent audit of every contract. The patient should obtain the actual clinician’s identity and the route for medical questions before and after the initial visit.

    The general FAQ describes a thirty-minute live phone or video consultation before any prescription, followed by direct portal contact during care. It also describes fifteen-minute follow-up appointments once a quarter, so scheduled check-ins are part of the stated relationship. Product pages begin with an online intake and physician review, which should be read alongside that live-visit commitment. Ask how the individual treatment changes the schedule and when a new examination is needed. The FAQ says asynchronous care is being explored rather than presenting it as the established first-visit model. Ongoing chat access does not guarantee an immediate response to an urgent symptom.

    Are labs required?

    Not mentioned

    The medical FAQ leaves laboratory work to the physician’s judgment based on the individual medical situation. Recent results may help the assessment, but the clinician decides whether additional tests are needed. This does not establish either a mandatory panel for everyone or a no-labs pathway. The reviewed public material also does not establish one universal patient testing price. Ask who orders the work, where it can be completed and how results are reviewed. A package including clinical access and medicine should not be assumed to cover every outside diagnostic expense.

    Ready to start with Big Easy Weight Loss?

    Prices and plans are set on the seller's own site.

    What it claims, and what it cites

    The named pharmacy network makes regulatory context important. FDA’s December 2025 Apothecary Pharma letter described sterile-production and other deficiencies. Its April 2026 ProRx letter discussed sterile-assurance problems and specified earlier recalls. A separate March 2025 BPI letter concerned an epinephrine nasal product and its labeling; that is not a finding about every BPI GLP-1 preparation. These records concern their named facilities and products, not every Big Easy order or current batch. Ask which source will fill the actual prescription and what current corrective-action information supports that choice. Registration or a broad standards claim does not equal approval of a compounded finished drug.

    Other products and treatment claims

    Physical training and other wellness services
    The wider catalog includes services outside the peptide prescription programs considered here.

    How it bills

    The current menu advertises twelve-week weight-treatment packages and eight-week NAD+ or sermorelin packages, with installment options. Those commitments should not be casually divided into calendar months. The pricing page charges $75 for the consultation, credited toward treatment or refunded if the applicant is not a suitable fit. The FAQ says there is no membership fee and that treatment payment is collected when the prescription goes to the pharmacy. It also says insurance filing and prior authorization are not supported. Obtain the pharmacy-specific quote and refund agreement. Published turnaround estimates differ between sections, so confirm the actual preparation and shipping timetable.

    For and against

    • For: Live physician consultation explicitly described
    • For: Direct clinical portal access and quarterly follow-up
    • For: Named pharmacies with some state limitations disclosed
    • For: Consultation charge credited toward eligible treatment
    • Against: Partner regulatory records require a sourcing discussion
    • Against: Package prices vary by pharmacy
    • Against: Complete cancellation and refund terms need confirmation
    • Against: Turnaround descriptions differ across the page

    The evidence behind what it sells

    Right for

    A patient seeking a direct physician relationship who will verify the specific pharmacy, prescription and multi-week package agreement.

    Look elsewhere if

    Someone choosing only from the starting figure or interpreting a pharmacy’s registration as proof of every compounded product’s safety.

    Other sellers for weight

    Big Easy Weight Loss

    Frequently asked questions

    Is the initial assessment described as a live appointment?
    Yes. The FAQ describes a thirty-minute phone or video consultation, with later portal access and quarterly follow-up.
    Are laboratory tests required for everyone?
    The FAQ leaves testing to the physician based on the individual medical situation. Recent results may be useful.
    Does one pharmacy warning establish that every order is affected?
    No. The finding must be matched to the actual facility, product and relevant period. Confirm the individual prescription’s source.
    Does a package amount establish a calendar-month price?
    No. The current menu uses eight- and twelve-week packages with installment options.

    Sources

    See what Big Easy Weight Loss prescribes today

    Big Easy Weight Loss sets its own prices, plans and the states it serves. Check them before you start.

    Written by Leah Garner from Big Easy Weight Loss’s own public pages, against the published methodology. No outcome is claimed first-hand and no score is given. A partnership never changes what this page says; see how the site is paid.